Dose response, safety, and efficacy of an extended-release formulation of lovastatin in adults with hypercholesterolemia.
Crouse
John R
JR
Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. jcrouse@wfubmc.edu
Lukacsko
Peter
P
Niecestro
Robert
R
Friedhoff
Lawrence
L
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008148:Lovastatin / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D003692:Delayed-Action Preparations; D008148:Lovastatin